Loading...
XLON
SVNS
Market cap5mUSD
Feb 11, Last price  
0.19GBP
Name

Graft Polymer (UK) Plc

Chart & Performance

D1W1MN
P/E
P/S
723.59
EPS
Div Yield, %
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
82.49%
Revenues
587k
+8.30%
029,000330,000690,858219,000542,000587,000
Net income
-3m
L+15.34%
-494,000-703,000-538,000-274,286-954,000-2,705,000-3,120,000
CFO
-1m
L-47.54%
-413,000-560,000-192,0001,000-254,000-2,360,000-1,238,000

Profile

Graft Polymer (UK) Plc engages in the research and development of polymer modification technologies and techniques in the United Kingdom and Europe. The company offers GRAFTABOND, a line of graft/block copolymers for combining various polymers with fiberglass, carbon fiber, mineral, natural fillers, and mixed polymer waste; GRAFTALEN, a line of reactive solid super-concentrates for polyolefin rheology modification, e-modulus enhancers, PET/PBT chain extenders, and AOX masterbatch; and GRAFTAPOR, a line of porous polymer-carriers for use in liquid chemicals. It also provides GRAFTAMID, a line of high-temperature elastomers based on nanostructured polyolefin-polyamide alloys for use in high-tech hardening modifiers in polyamide compounds, as well as use as an independent compound in hot melt adhesives; and GRAFTAKIT, a reactive liquid or solid super-concentrates on polymeric porous media for carrying out reaction extrusion and modification of compounds. In addition, the company offers GRAFTALLOY, a line of polymer-polymer nano-alloys to increase abrasion and temperature resistance, and impact strength, as well as reduce friction coefficient; GRAFTASYNT, a line of synthetic products comprising halogen-free flame retardants; and GRAFTAMER, a thermo-reversible crosslinking, self-hardening, and self-healing smart polymer with shape memory, etc. Graft Polymer (UK) Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
IPO date
Jan 06, 2022
Employees
9
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122021‑052020‑052019‑052018‑05
Income
Revenues
587
8.30%
542
-21.55%
Cost of revenue
2,797
3,250
Unusual Expense (Income)
NOPBT
(2,210)
(2,708)
NOPBT Margin
Operating Taxes
(115)
Tax Rate
NOPAT
(2,210)
(2,593)
Net income
(3,120)
15.34%
(2,705)
886.20%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,135
BB yield
Debt
Debt current
12
4
Long-term debt
56
36
Deferred revenue
Other long-term liabilities
Net debt
(87)
(1,600)
Cash flow
Cash from operating activities
(1,238)
(2,360)
CAPEX
(232)
(718)
Cash from investing activities
(232)
(718)
Cash from financing activities
4,135
FCF
(1,061)
(3,600)
Balance
Cash
155
1,640
Long term investments
Excess cash
126
1,613
Stockholders' equity
(4,975)
(2,447)
Invested Capital
7,035
7,000
ROIC
ROCE
EV
Common stock shares outstanding
104,057
103,589
Price
Market cap
EV
EBITDA
(2,033)
(2,595)
EV/EBITDA
Interest
3
4
Interest/NOPBT